La Jolla Pharmaceutical Co LJPC:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
Last | 11:15 AM EDT
3.86quote price arrow down-0.08 (-2.03%)
Volume
21,128
52 week range
3.40 - 5.69
Loading...
  • Open3.79
  • Day High3.98
  • Day Low3.76
  • Prev Close3.94
  • 52 Week High5.69
  • 52 Week High Date06/03/21
  • 52 Week Low3.40
  • 52 Week Low Date05/24/21

Key Stats

  • Market Cap98.66M
  • Shares Out25.56M
  • 10 Day Average Volume0.07M
  • Dividend-
  • Dividend Yield-
  • Beta1.91
  • YTD % Change-17.2

KEY STATS

  • Open3.79
  • Day High3.98
  • Day Low3.76
  • Prev Close3.94
  • 52 Week High5.69
  • 52 Week High Date06/03/21
  • 52 Week Low3.40
  • 52 Week Low Date05/24/21
  • Market Cap98.66M
  • Shares Out25.56M
  • 10 Day Average Volume0.07M
  • Dividend-
  • Dividend Yield-
  • Beta1.91
  • YTD % Change-17.2

RATIOS/PROFITABILITY

  • EPS (TTM)0.14
  • P/E (TTM)28.07
  • Fwd P/E (NTM)48.25
  • EBITDA (TTM)3.951M
  • ROE (TTM)-933.89%
  • Revenue (TTM)52.01M
  • Gross Margin (TTM)82.06%
  • Net Margin (TTM)10.08%
  • Debt To Equity (MRQ)-0.00%

EVENTS

  • Earnings Date08/03/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On La Jolla Pharmaceutical Co

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
La Jolla Pharmaceutical Company is primarily engaged in the commercialization of therapies for patients suffering from life-threatening diseases. Its product pipeline includes GIAPREZA (angiotensin II) and XERAVA (eravacycline). Its GIAPREZA injection is a vasoconstrictor indicated to increase blood pressure in adults with septic or other distributive shocks. The GIAPREZA is used for the treatment of refractory hypotension in adults with septic or other distributive shocks....
Kevin Tang
Chairman of the Board
Larry Edwards
President, Chief Executive Officer, Director
Michael Hearne CPA
Chief Financial Officer
Address
201 JONES ROAD, SUITE 400
Waltham, MA
02451
United States

Top Peers

SYMBOLLASTCHG%CHG
AZYO
Aziyo Biologics Inc
6.21+0.01+0.19%
RVLP
RVL Pharmaceuticals PLC
1.38UNCHUNCH
MEIP
MEI Pharma Inc
0.4657-0.0199-4.098%
AQST
Aquestive Therapeutics Inc
1.05UNCHUNCH
CDXC
Chromadex Corp
1.76-0.15-7.85%